Media

Chem Outsourcing Conference 2017

  • Date: 18-20 September 2017
  • Place: New Jersey

Bio International Conference 2017

  • Date: 19-22 June 2017
  • Place: San Diego

Bio Asia 2017

  • Date: 6-9 February 2017
  • Place: Hyderabad

Laxai – Ferrer (ABAC Therapeutics)

  • To develop First in class (FIC) antibiotics against life threatening infections.
  • Laxai has been a strategic partner to ABAC Therapeutics.
  • Technical platform validation.
  • Delivered Pre-clinical Candidate with clean IP acting against gram-negative bacteria with unique mode of action.

http://www.abactherapeutics.com/strategic-partners/

Aptose Biosciences Announces Exclusive collaborations with Laxai for New Multi-Targeting Epigenetic Therapeutic Agents (10 November 2015)

  • Laxai to Design Next Generation Epigenetic Therapeutics.
  • Laxai has contributed in reviewing the target selection and devised the unique strategy with clear differentiation.

https://globenewswire.com/news-release/2015/11/10/785694/10155781/en/Aptose-Biosciences-Announces-Collaborations-for-New-Multi-Targeting-Epigenetic-Therapeutic-Agents.html